ReviewCardiovascular drugs and therapy2017

The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease.

Paul P Dobesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.